HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth Jonckers Selected Research

Elisabeth Jonckers Research Topics

Disease

2Epilepsy (Aura)
12/2023 - 03/2017
2Status Epilepticus (Complex Partial Status Epilepticus)
01/2021 - 03/2017
2Inflammation (Inflammations)
03/2017 - 01/2013
2Alzheimer Disease (Alzheimer's Disease)
01/2016 - 04/2015
1Autism Spectrum Disorder
12/2023
1Intellectual Disability (Idiocy)
12/2023
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2023
1Hypothyroidism
01/2022
1Neuroinflammatory Diseases
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Autistic Disorder (Autism)
01/2016
1Nervous System Diseases (Neurological Disorders)
01/2016
1Memory Disorders (Memory Loss)
04/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2015
1Amyloid Plaque
01/2013
1Amyloidosis
01/2013

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
12/2023 - 03/2017
22- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamideIBA
01/2021 - 03/2017
2Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2017
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2016 - 04/2015
2Cholinergic Agents (Cholinergics)IBA
01/2016 - 04/2015
1Thyroid HormonesIBA
01/2022
1Testosterone (Sustanon)FDA Link
01/2022
1PK 11195 (PK11195)IBA
01/2021
1Kainic Acid (Kainate)IBA
01/2021
1Staphylococcal Protein A (Protein A)IBA
03/2017
1milamelineIBA
04/2015
1Scopolamine (Hyoscine)FDA Link
04/2015
1Amyloid (Amyloid Fibrils)IBA
01/2013